TRIM37 Activators
TRIM37 Activators encompass a spectrum of chemical compounds that indirectly promote the functional activity of TRIM37 by modulating various cellular signaling cascades. Forskolin, through the activation of adenylate cyclase, and Sildenafil, by inhibiting phosphodiesterase-5, both lead to elevated cAMP and cGMP levels, respectively. These cyclic nucleotides activate protein kinase A and protein kinase G, which may subsequently enhance the ubiquitin ligase activity of TRIM37 via phosphorylation-dependent mechanisms. In parallel, PMA acts as a potent activator of protein kinase C, which can phosphorylate a range of substrates that modulate TRIM37 functionality, potentially enhancing its E3 ubiquitin ligase activity. Ionomycin serves as a catalyst for intracellular calcium increase, potentially activating calmodulin-dependent kinases that could augment the function of TRIM37 by facilitating its interaction with other regulatory proteins.
The influence of TRIM37 activators extends to the modulation of protein interactions and stability. Lithium chloride and SB216763, both GSK-3β inhibitors, indirectly enhance TRIM37's activity by altering protein turnover within the Wnt signaling pathway-where TRIM37 may play a role. Curcumin and Resveratrol operate through inhibition of NF-κB signaling and activation of SIRT1, respectively, which may result in a reduced competition for ubiquitination substrates or deacetylation of proteins related to TRIM37 function, indirectly enhancing its ubiquitin ligase activity. EGCG's role as a kinase inhibitor may make substrates more available for TRIM37-mediated ubiquitination. Furthermore, compounds like DBeQ disrupt the normal protein degradation machinery by inhibiting the p97 ATPase, leading to an accumulation of ubiquitinated proteins that necessitate enhanced TRIM37 activity to manage protein turnover within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to an increase in cAMP levels. Elevated cAMP enhances the activity of TRIM37 by promoting protein kinase A (PKA) phosphorylation events that could impact proteins that interact with TRIM37, thus enhancing its E3 ubiquitin ligase activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate substrates that modify the function of TRIM37. PKC-mediated signaling may enhance the E3 ubiquitin ligase activity of TRIM37 by modulating its localization or interaction with specific substrates. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as a calcium ionophore, raising intracellular calcium levels. Elevated calcium can activate calmodulin-dependent kinases, potentially enhancing the function of TRIM37 by affecting its conformation or promoting its interaction with regulatory proteins. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium acts on the Wnt signaling pathway by inhibiting GSK-3β, leading to stabilization of β-catenin. This can indirectly enhance TRIM37 activity by affecting protein turnover and stability in pathways where TRIM37 is active. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin has various cellular targets and can inhibit NF-κB signaling. This inhibition may reduce competition for ubiquitination substrates, potentially enhancing the role of TRIM37 in ubiquitin-mediated protein degradation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG, a known kinase inhibitor, may enhance TRIM37 activity by inhibiting kinases that modify TRIM37 substrates, thus making them more available for ubiquitination by TRIM37. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates SIRT1, which is involved in deacetylation of proteins. Activation of SIRT1 can enhance TRIM37 activity indirectly by deacetylating substrates or regulatory proteins associated with TRIM37, affecting its ligase activity. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
SB216763 is a GSK-3β inhibitor that could enhance TRIM37 function by stabilizing proteins within the Wnt pathway, a context where TRIM37 may have a role, thus indirectly enhancing the protein's activity. | ||||||
DBeQ | 177355-84-9 | sc-499943 | 10 mg | $330.00 | 1 | |
DBeQ is a selective ATP-competitive inhibitor of p97, an AAA ATPase involved in various cellular processes including protein degradation. Inhibition of p97 could enhance TRIM37 activity by affecting the turnover of ubiquitinated proteins. | ||||||